Imaging of 3D Tissue-Engineered Models of Oral Cancer Using 890 and 1300 nm Optical Coherence Tomography

Optical coherence tomography (OCT) generates its primary form of contrast from elastic backscatter. It is now the gold standard technique for retinal screening and is emerging rapidly in cardiovascular research however it remains a research goal to establish it to the same degree in epithelial cancer detection and diagnosis. In this report we compare two different OCT systems: an 890 nm spectrometer-based OCT system with 2.5 µm axial resolution and a 1300 nm swept-source OCT system with 7.5 µm axial resolution to determine the effect of these different OCT parameters on the endogenous backscatter contrast of dysplastic/malignant oral mucosa models relative to normal mucosa models. Tissue-engineered oral mucosa models constructed with a dysplastic cell line (DOK), a malignant cell line (Cal27) and normal cell were imaged with both of these OCT platforms and comparisons made with regard to apparent epithelial thickness and the visibility of the epithelium relative to the underlying stroma. For the Cal27’s, hematoxylin and eosin staining confirmed the formation of a keratinized layer superficial to a thickened layer of viable cells on top of the stroma. The keratinized layer presented as a hyperreflective thickened layer superficial to a darker region on both OCT platforms. The keratinized layer caused a steep fall in signal at 890 nm, making it difficult to visualise underlying structures, whereas 1300 nm OCT clearly visualized both the epithelial cells and the stroma lying beneath. For the DOK cells, hematoxylin and eosin staining confirmed the formation of an epithelial layer frequently presenting an abnormal morphology especially at the epidermal/stromal junction, with features such as infiltrating, bulbous rete pegs. These were more clearly visualized under 890 nm OCT.

These observations show that 890 nm OCT retains some of its known advantages of higher contrast between anatomical tissue layers when used to observe dysplastic and malignant 3D oral mucosa constructs. However 1300 nm OCT is confirmed to possess a greater ability to image the full thickness of the model epithelia and in particular it is more suited to imaging through the keratinized layer.

1. Collier T., Lacy A., Richards-Kortum R., Malpica A., Follen M. Near real-time confocal microscopy of amelanotic tissue: detection of dysplasia in ex vivo cervical tissue. Acad Radiol 2002; 9(5): 504–512, http://dx.doi.org/10.1016/s1076-6332(03)80326-4.
2. Hoffman A., Goetz M., Vieth M., Galle P.R., Neurath M.F., Kiesslich R. Confocal laser endomicroscopy: technical status and current indications. Endoscopy 2006; 38(12): 1275–1283, http://dx.doi.org/10.1055/s-2006-944813.
3. Zysk A.M., Nguyen F.T., Oldenburg A.L., Marks D.L., Boppart S.A. Optical coherence tomography: a review of clinical development from bench to bedside. J Biomed Opt 2007; 12(5): 051403, http://dx.doi.org/10.1117/1.2793736.
4. Coleman A.J., Richardson T.J., Orchard G., Uddin A., Choi M.J., Lacy K.E. Histological correlates of optical coherence tomography in non-melanoma skin cancer. Skin Res Technol 2013; 19(1): e10–e19, http://dx.doi.org/10.1111/j.1600-0846.2012.00626.x.
5. Cimalla P., Walther J., Mehner M., Cuevas M., Koch E. Simultaneous dual-band optical coherence tomography in the spectral domain for high resolution in vivo imaging. Opt Express 2009; 17(22): 19486–19500, http://dx.doi.org/10.1364/OE.17.019486.
6. Alex A., Povazay B., Hofer B., Popov S., Glittenberg C., Binder S., Drexler W. Multispectral in vivo three-dimensional optical coherence tomography of human skin. J Biomed Opt 2010; 15(2): 026025, http://dx.doi.org/10.1117/1.3400665.
7. Holmes J. In vivo real-time optical coherence tomography imaging of Drosophila for cardiovascular research. Nat Methods 2009; 6(10): III–IV.
8. Hamdoon Z., Jerjes W., Upile T., McKenzie G., Jay A., Hopper C. Optical coherence tomography in the assessment of suspicious oral lesions: an immediate ex vivo study. Photodiagnosis Photodyn Ther 2013; 10(1): 17–27, http://dx.doi.org/10.1016/j.pdpdt.2012.07.005.
9. Bhargava S., Chapple C.R., Bullock A.J., Layton C., MacNeil S. Tissue-engineered buccal mucosa for substitution urethroplasty. BJU Intern 2004; 93(6): 807–811, http://dx.doi.org/10.1111/j.1464-410X.2003.04723.x.
10. Bhargava S., Patterson J.M., Inman R.D., MacNeil S., Chapple C.R. Tissue-engineered buccal mucosa urethroplasty — clinical outcomes. Eur Urol 2008; 53(6): 1263–1271, http://dx.doi.org/10.1016/j.eururo.2008.01.061.
11. Colley H.E., Hearnden V., Jones A.V., Weinreb P.H., Violette S.M., Macneil S., Thornhill M.H., Murdoch C. Development of tissue-engineered models of oral dysplasia and early invasive oral squamous cell carcinoma. Br J Cancer 2011; 105(10): 1582–1592, http://dx.doi.org/10.1038/bjc.2011.403.
12. Hearnden V. Developing tissue engineered models of oral mucosa and oral cancer to study novel therapeutic and diagnostic techniques. PhD Thesis. University of Sheffield; 2011.
13. Smith L.E., Hearnden V., Lu Z., Smallwood R., Hunter K.D., Matcher S.J., Thornhill M.H., Murdoch C., MacNeil S. Evaluating the use of optical coherence tomography for the detection of epithelial cancers in vitro. J Biomed Opt 2011; 16(11): 116015, http://dx.doi.org/10.1117/1.3652708.
14. Enfield J., Jonathan E., Leahy M. In vivo imaging of the microcirculation of the volar forearm using correlation mapping optical coherence tomography (cmOCT). Biomed Opt Express 2011; 2(5): 1184–1193, http://dx.doi.org/10.1364/BOE.2.001184.

Boadi J., Fernandes J., Mittar S., Hearnden V., Lu Z., MacNeil S., Thornhill M.H., Murdoch C., Hunter K.D., Matcher S.J. Imaging of 3D Tissue-Engineered Models of Oral Cancer Using 890 and 1300 nm Optical Coherence Tomography. Sovremennye tehnologii v medicine 2015; 7(1): 60, https://doi.org/10.17691/stm2015.7.1.08